Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)
Alto Neuroscience's (ANRO) quarterly Interest & Investment Income came in at $1.6 million in Q1 2026, down 14.56% year-on-year from $1.8 million in Q1 2025, and little changed quarter-over-quarter from $1.6 million in Q4 2025.
Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Interest & Investment Income across 4 years of filings, most recently posting $1.6 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.6 million, down 14.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 30.52% YoY), and the FY2025 annual result was $6.6 million, down 25.4% from the prior year.
- Interest & Investment Income came in at $1.6 million for Q1 2026 at Alto Neuroscience, roughly flat from $1.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.7 million in Q2 2024 to a low of $230000.0 in Q1 2023.
- The 4-year median for Interest & Investment Income is $1.6 million (2025), against an average of $1.5 million.
- Across the five-year window, Interest & Investment Income jumped 577.39% in 2024 and sank 38.72% in 2025, its largest moves.
- Alto Neuroscience's Interest & Investment Income stood at $738000.0 in 2023, then soared by 189.3% to $2.1 million in 2024, then retreated by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
- The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 738,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Jun 30, 2023 | 667,000.00 |
| Mar 31, 2023 | 230,000.00 |